Investor Presentaiton

Covid-19 Vaccination Will Restore Public Confidence Health Workers will get the priority, followed by Public Officers / Services and the Elderly Vaccination Targets & Needs 181.5 SINOVAC Procurement of Vaccines Total Firm Order (FO): 329.5 millions doses Total additional options (AO): 334 millions doses Total potential for procurement: 663.5 millions doses FO: 125.5 million doses NOVAVAC FO: 50 million doses COVAX FO: 54 million doses ASTRAZENECA FO: 50 million doses million people AO: 100 million doses AO: 80 million doses AO: 54 million doses AO: 50 million doses "Gotong Royong❞ 426.8 million doses Vaccine is a special vaccine program for workers whose "Gotong Royong" Vaccine (20 million doses) Sinopharm Sputnik V implementation is the responsibility of the company 15 million 20 million History of Vaccines Arrival in Indonesia Total Dosage 1.2 M Туре Ready To Use Date (06/12/20) 1.8 M Ready To Use (31/12/20) 16,5 M Bulk (Raw Materials) (12/01/21) 11 M Bulk (Raw Materials) (02/02/21) sinovac 10 M Bulk (Raw Materials) (02/03/21) 16 M Bulk (Raw Materials) (25/03/21) 6 M Bulk (Raw Materials) (18/04/21) Source: Coordinating Ministry for Economic Affairs Vaccination Stages: 1 HEALTH WORKERS Vaccinations are carried out for health workers in 34 provinces 1.5 M VACCINATION PERIOD JAN-FEB 2021 3 VULNERABLE COMMUNITIES Communities in areas with a high risk of transmission 63,9 M 2 PUBLIC OFFICERS 17.3 M ELDERLY 21.6 M VACCINATION PERIOD FEB-JUN 2021 OTHER COMMUNITIES With a cluster approach according to vaccine availability 77.7 M VACCINATION PERIOD APR 2021 - DEC 2021 + AstraZeneca Total Dosage Type Date 1.1 M Efficacy: 70,4%* 3.8 M Ready (08/0 To Use 3/21) Ready (26/0 To Use 4/21) Total Vaccine 3 M Finished Vaccine Sinovac; 4,9 M Astrazeneca; 59,5 M semi-finished Vaccine Sinovac

View entire presentation